Retina CME

Uveitic Macular Edema: Challenges and New Opportunities in Treatment

Uveitic macular edema (UME) is the most common cause of vision loss in patients with uveitis, regardless of the anatomical type. The presence of UME has been shown to be associated with substantial… More >>

Best of Ophthalmology Research: Targeting the Angiopoietin/Tie2 Pathway to Achieve Vascular Integrity in Retinal Vascular Diseases

The need to identify alternate molecular targets for the management of retinal vascular diseases has been highlighted by the proportion of patients who have either a suboptimal or lack of response to… More >>

Retina360: Advances in the Management of Retinal Disease

Optimization of visual outcomes for patients with retinal diseases continues to evolve, as improved imaging modalities, surgical devices, as well as emerging and newly approved therapeutic… More >>

Geographic Atrophy: Emerging Treatment Options That Focus on the Complement Cascade

The advanced form of age-related macular degeneration (AMD), geographic atrophy (GA) leads to a progressive and irreversible loss of visual function. Genetic variants of several complement factor… More >>

Diabetic Macular Edema: Inflammatory Markers and Their Role as Potential Therapeutic Targets

Diabetic macular edema (DME) is a leading cause of visual impairment. While treatment advances have improved the overall visual outcomes for most patients with DME, there continue to be unmet needs… More >>

Tie2 Activation as an Approach to Retinal Disease Treatment: New Perspectives

Significant visual and anatomic improvements through the integration of intravitreal anti-vascular endothelial growth factor (VEGF) therapies are well reported in the management of retinal and… More >>

X-Linked Retinitis Pigmentosa and Gene Therapy: More Than Meets the Eye

X-linked retinitis pigmentosa (XLRP) is a rare, inherited retinal disease that leads to gradual vision loss in boys and young men. Patients usually present with early-onset night blindness followed… More >>

Expert Perspectives on Challenging Cases in Neovascular Age-Related Macular Degeneration

Intravitreal therapy has rapidly evolved to become a mainstay of treatment for many retinal diseases, and it offers many patients delayed or arrested disease progression and, in some, the possibility… More >>

Optimizing the Management of Retinal Vein Occlusion Through Imaging and Treatment Regimens

Prompt diagnosis and timely initiation of anti-vascular endothelial growth factor (VEGF) therapies are imperative for optimal visual acuity gains for patients with central or branch retinal vein… More >>

Addressing Anti-VEGF Durability Issues Through Novel Surgical Approaches for the Treatment of nAMD and DME

Intravitreal anti–vascular endothelial growth factor (VEGF) therapy has revolutionized the management paradigm for patients with retinal vascular diseases, yet there is still an unmet need to address… More >>